| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hertfordshire EN6 3LD, England
Regulation of the expression of the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) has been investigated in a number of human lymphoblastoid cell lines. In a number of Mex- cell lines that do not express methyltransferase activity, CpG sequences in the mgmt gene were hypomethylated with respect to methyltransferase-expressing Mex+ lines. In the cell line GM1953(S), in which the mgmt gene is coregulated with the thymidine kinase and galactokinase genes, reexpression of all three activities was experimentally induced. In this case, the mgmt gene in the nonexpressing cells was found to be hypermethylated and underwent a demethylation at CpG sequences that was coincident with the reappearence of the mgmt mRNA and the three enzyme activities. The simultaneous silencing of three activities in these cells was correlated with an increase in DNA 5-methylcytosine that was widespread thoughout the genome. The data indicate that MGMT expression can be controlled epigenetically in human lymphoid cell lines, although the relationship between cytosine methylation and MGMT expression is complex. Furthermore, the rapid alterations in methylation in GM1953(S) cells indicate the existence of signals that can induce widespread and abrupt alterations in cytosine methylation in human cells in culture.
1 To whom requests for reprints should be addressed.
Received 3/18/92. Accepted 7/22/92.
This article has been cited by other articles:
![]() |
K. K. Bhakat and S. Mitra CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration Carcinogenesis, August 1, 2003; 24(8): 1337 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bearzatto, M. Szadkowski, P. Macpherson, J. Jiricny, and P. Karran Epigenetic Regulation of the MGMT and hMSH6 DNA Repair Genes in Cells Resistant to Methylating Agents Cancer Res., June 1, 2000; 60(12): 3262 - 3270. [Abstract] [Full Text] |
||||
![]() |
C. Schmutte, G. Tombline, K. Rhiem, M. M. Sadoff, R. Schmutzler, A. von Deimling, and R. Fishel Characterization of the Human Rad51 Genomic Locus and Examination of Tumors with 15q14-15 Loss of Heterozygosity (LOH) Cancer Res., September 1, 1999; 59(18): 4564 - 4569. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hampson, O. Humbert, P. Macpherson, G. Aquilina, and P. Karran Mismatch Repair Defects and O6-Methylguanine-DNA Methyltransferase Expression in Acquired Resistance to Methylating Agents in Human Cells J. Biol. Chem., November 7, 1997; 272(45): 28596 - 28606. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |